Newsroom

test44 https://www.cytel.com/news/rocheqba

test44 https://www.cytel.com/news/cytel-designed-and-led-together-trial-wins-society-of-clinical-trials-david-sackett-trial-of-the-year-award

test44 https://www.cytel.com/news/closing-the-biometrics-skills-and-services-gap-in-australia

test44 https://www.cytel.com/news/guardian-research-network-and-cytel-announce-presentation-at-ispor-2022-detailing-covid-19s-impact-on-breast-cancer

test44 https://www.cytel.com/news/scientific-computing-world-cytel-appoints-first-cmo-to-accelerate-the-expansion-of-analytics-and-innovation

test44 https://www.cytel.com/news/reuters-health-information-covers-cytels-economic-model-for-lgbtq-study

test44 https://www.cytel.com/news/cytel-appoints-first-cmo-propelling-expansion-of-analytics-and-innovation-available-to-clinicians-in-drug-development

test44 https://www.cytel.com/news/wall-street-journal-reports-finding-of-cytel-designed-covid-19-trial

test44 https://www.cytel.com/news/new-york-daily-news-features-cytel-study-widely-debunked-and-dangerous-lgbtq-conversion-therapy-costs-u.s.-9b-per-year-study-finds

test44 https://www.cytel.com/news/newsweek-cites-cytel-research-conversion-therapy-costs-u.s.-over-9-billion-a-year-study

test44 https://www.cytel.com/news/cnn-reports-on-cytel-study-conversion-therapy-is-harmful-to-lgbtq-people-and-costs-society-as-a-whole-study-says

test44 https://www.cytel.com/news/cytel-research-in-nbc-news-conversion-therapy-costs-u.s.-over-9-billion-a-year-study-finds

test44 https://www.cytel.com/news/cytel-in-the-news-bloomberg-news-reports-on-cytels-groundbreaking-heor-study

test44 https://www.cytel.com/news/cytel-in-forbes-dangerous-discredited-lgbtq-conversion-therapy-costs-u.s.-more-than-9-billion-each-year-study-finds

test44 https://www.cytel.com/news/the-hills-changing-america-series-reports-on-cytels-research-on-lgbtq-forced-conversion-therapy

test44 https://www.cytel.com/news/new-study-finds-conversion-therapy-and-its-associated-harms-cost-the-u.s.-an-estimated-9.23-billion-annually

test44 https://www.cytel.com/news/new-cytel-authored-paper-optimal-adaptive-promising-zone-designs-by-cyrus-mehta-and-pralay-senchaudhuri

test44 https://www.cytel.com/news/cytel-2021-webinars

test44 https://www.cytel.com/news/whats-the-deal-with-ivermectic-and-covid-interview-with-dr.-edward-mills

test44 https://www.cytel.com/news/modern-trials-could-benefit-from-historical-approach-an-interview-with-dr.-pantelis-vlachos

test44 https://www.cytel.com/news/statistical-innovation-could-elevate-global-clinical-trials-outsourcing-pharma

test44 https://www.cytel.com/news/cytel-and-pulse-infoframe-deploy-new-real-world-data-solutions-to-transform-rare-disease-research-landscape

test44 https://www.cytel.com/news/webinar-series-expanding-applications-of-master-protocols

test44 https://www.cytel.com/news/cytel-discusses-its-covid-19-trial-tracker-an-interview-with-ed-mills

test44 https://www.cytel.com/news/adapt-update-the-benefits-of-bayesian

test44 https://www.cytel.com/news/recent-fluvoxamine-covid-benefits-discovered-using-cytel-designed-platform-trial

test44 https://www.cytel.com/news/cytel-solara-selected-as-2021-citeline-awards-finalist

test44 https://www.cytel.com/news/cytel-calls-for-statistical-innovation-to-be-mobilized-for-global-health-challenges

test44 https://www.cytel.com/news/cytel-announces-new-vp-scientific-strategy-innovation-to-further-drive-bayesian-innovation

test44 https://www.cytel.com/news/general-release-of-solara

test44 https://www.cytel.com/news/cytels-east-bayes-broadens-simplifies-access-to-complex-bayesian-clinical-trial-designs

test44 https://www.cytel.com/news/nordic-capital-and-astorg-invest-in-pharmaceutical-technology-and-advanced-analytics-company-cytel

test44 https://www.cytel.com/news/cytel-acquires-heor-experts-purple-squirrel-economics

test44 https://www.cytel.com/news/cytel-ushers-in-new-era-of-optimized-trial-design-with-launch-of-solara

test44 https://www.cytel.com/news/cytel-expands-unique-trial-for-early-covid-19-treatments-in-global-south

test44 https://www.cytel.com/news/cytel-acquires-laiya-consulting

test44 https://www.cytel.com/news/cytel-announces-east-alloy-for-easy-access-to-verified-bayesian-and-innovative-methods

test44 https://www.cytel.com/news/global-covid-19-clinical-trial-tracker-launched-by-cytel

test44 https://www.cytel.com/news/cytel-joins-newdigs-initiative-at-mit-as-a-strategic-partner

test44 https://www.cytel.com/news/cytel-champions-precision-oncology-master-protocol-trial-designs

test44 https://www.cytel.com/news/cytel-mtek-rwa-expansion

test44 https://www.cytel.com/news/press_release_complex_innovative_trial_design_symposium

test44 https://www.cytel.com/news/cytel-launches-east-on-demand-press-release

test44 https://www.cytel.com/news/cytel-axio-join-forces

test44 https://www.cytel.com/news/cytel-names-joshua-schultz-as-chief-executive-officer

test44 https://www.cytel.com/news/cytel-transforms-biopharmaceutical-go/no-go-decision-making-with-ok-go-software

test44 https://www.cytel.com/news/cytel-wins-best-cro-specialist-provider-at-2018-scrip-awards

test44 https://www.cytel.com/news/cytel-announces-launch-of-east-6.5

test44 https://www.cytel.com/news/news-announcing-enforesys-2.0

test44 https://www.cytel.com/news/cytel-announces-launch-of-east-lite

test44 https://www.cytel.com/news/cytel-announced-as-a-finalist-in-informa-care-awards

test44 https://www.cytel.com/news/cytel-congratulates-lipopharma-and-clinglio-on-grant-award

test44 https://www.cytel.com/news/cytel-announced-as-finalists-at-informa-care-awards